The effect of lidocaine and magnesium sulfate on prevention of ventricular fibrillation in coronary artery bypass grafting surgery
المؤلفون المشاركون
Janati, M.
Vaziri, M. T. Moeen
Jouibar, R.
Akhlagh, S. H. A.
المصدر
Iranian Red Crescent Medical Journal
العدد
المجلد 12، العدد 3 (31 مايو/أيار 2010)، ص ص. 298-301، 4ص.
الناشر
تاريخ النشر
2010-05-31
دولة النشر
الإمارات العربية المتحدة
عدد الصفحات
4
التخصصات الرئيسية
الموضوعات
الملخص EN
Background : one of the most common events, after the release of aortic cross-clamp in patients undergoing coronary artery bypass grafting surgery is reperfusion induced ventricular fibrillation, which occurs in 74 % of 96 % of patients.
Regarding the controversies over the use of lidocaine or magnesium sulfate for the prevention of ventricular fibrillation following the release of aortic cross-clamp, this study was designed to compare the effectiveness of magnesium sulfate and lidocaine to suppress ventricular fibrillation.
Methods : in a double blind, prospective, randomized, controlled trial study, 76 patients who were candidates for elective coronary artery bypass grafting surgery were divided into three groups including Group A (lidocaine, n = 26), group B (magnesium sulfate, n = 25), and group C (normal saline, n = 26).
Lidocaine (1.5 mg / Kg), magnesium sulfate (30 mg / Kg) and normal saline were administered 5 minutes before the release of aortic cross clamp.
Results : the incidence of ventricular fibrillation significantly decreased in patients receiving magnesium sulfate (12 % vs.
26.9 % and 44 % in patients who received lidocaine and normal saline, respectively) There was no statistically significant difference between the groups with respect to age, ejection fraction (L / min), anesthetic time (min), cross-clamping time (min), PH, HCT (%), and serum K + level (meq).
Conclusion : the administration of lidocaine and magnesium sulfate before the release of aortic cross-clamp reduces the incidence of postoperative ventricular fibrillation in adult patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass.
In our study, magnesium sulfate was more efficient in prevention of ventricular fibrillation than lidocaine.
Administration of magnesium sulfate (30 mg / kg) caused no toxic effect and was safe for patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Vaziri, M. T. Moeen& Jouibar, R.& Akhlagh, S. H. A.& Janati, M.. 2010. The effect of lidocaine and magnesium sulfate on prevention of ventricular fibrillation in coronary artery bypass grafting surgery. Iranian Red Crescent Medical Journal،Vol. 12, no. 3, pp.298-301.
https://search.emarefa.net/detail/BIM-252862
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Akhlagh, S. H. A.…[et al.]. The effect of lidocaine and magnesium sulfate on prevention of ventricular fibrillation in coronary artery bypass grafting surgery. Iranian Red Crescent Medical Journal Vol. 12, no. 3 (May. 2010), pp.298-301.
https://search.emarefa.net/detail/BIM-252862
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Vaziri, M. T. Moeen& Jouibar, R.& Akhlagh, S. H. A.& Janati, M.. The effect of lidocaine and magnesium sulfate on prevention of ventricular fibrillation in coronary artery bypass grafting surgery. Iranian Red Crescent Medical Journal. 2010. Vol. 12, no. 3, pp.298-301.
https://search.emarefa.net/detail/BIM-252862
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 301
رقم السجل
BIM-252862
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر